{
  "docId": "019de511-f853-7628-af24-036a16ee5936",
  "docSlug": "9bca89e90a20fd8ffdc155bdf27f844e",
  "documentTitle": "Vale | Investor Day Presentation Deck | 79 slides",
  "authorId": "vale",
  "authorName": "Vale",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 72,
  "pageCount": 79,
  "prevPage": 71,
  "nextPage": 73,
  "slideType": "comparison_table",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 15,
  "notes": "The table highlights divestments and operational improvements as the primary drivers for reducing cash outflows.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-f853-7628-af24-036a16ee5936/72",
  "deckHref": "/decks/019de511-f853-7628-af24-036a16ee5936",
  "deckJsonHref": "/decks/019de511-f853-7628-af24-036a16ee5936.json",
  "deckAnchorHref": "/decks/019de511-f853-7628-af24-036a16ee5936#slide-72",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.06,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1 VNC result in 2021 does not consider the US$ 555 million paid for the divestment. 3 Including Samarco's working capital needs. 3 Including Biopalma and CSP needs",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b125f22-f6c8-4548-ae04-84267ce93210",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.88,
        "x": 0.06,
        "y": 0.315
      },
      "kind": "table",
      "text": "US$ million 2019 2020 2021E 2022 onwards VNC 370 300 70 - Moatize 790 1140 320 - Samarco 100 160 20 - Others 220 300 40 - Total 1480 1900 450 - Main measures VNC sold to Trafigura; Moatize break-even; Samarco resumption; Biopalma sold",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64e3c945-a306-4f37-850f-8fb75a6a9b6d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.06,
        "y": 0.1
      },
      "kind": "title",
      "text": "... leading to a significant decrease of our cash drains",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "478665a0-c135-4b36-ba5b-3360ccf86636",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 79,
      "from": 21,
      "beatId": "0e51f5dd-7c99-4235-8e08-2350a1d8282e",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "Growth strategy and next steps",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}